Back to top

AMENDMENT AGREEMENT

Purchase and Sale Agreement

AMENDMENT AGREEMENT | Document Parties: GENTA INCORPORATED You are currently viewing:
This Purchase and Sale Agreement involves

GENTA INCORPORATED

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: AMENDMENT AGREEMENT
Date: 8/12/2009
Industry: Biotechnology and Drugs     Sector: Healthcare

AMENDMENT AGREEMENT, Parties: genta incorporated
50 of the Top 250 law firms use our Products every day

 

AMENDMENT AGREEMENT

 

This Amendment Agreement (this “ Agreement ”) shall be effective as of August 6, 2009 (the “ Effective Date ”), by and among Genta Incorporated , a Delaware corporation (the “ Company ”), and the undersigned parties whose names are set forth on Exhibit A attached hereto (each a “ Holder ” and collectively the “ Holders ”).  Capitalized terms used but not defined herein shall have the meanings given to such terms in the April 2009 Consent Agreement and/or the July 2009 Consent Agreement.

 

Whereas , in July 2009, in order to facilitate the consummation of one or more financing transactions, which could have included private placements or public offerings, under which the Company desired to raise an aggregate in all such transactions of up to $10,000,000 through the sale of securities consisting of (i) up to $7,000,000 in principal amount of July 2009 Notes, (ii) up to $3,000,000 of common stock of the Company (the “ Common Stock ”) and (iii) related warrants (the “ Financing ”), on the terms set forth in that certain Securities Purchase Agreement dated as of July 7, 2009, by and among the Company and the Purchasers listed on Exhibit A thereto (the “ Purchase Agreement ”), the parties entered into the July 2009 Consent Agreement;

 

Whereas , the Company and the Holders desire to extend the date of the additional closing under the Purchase Agreement to, among other things, allow the Company additional time to complete the public offering referenced in Section 1.2(b) of the Purchase Agreement; and

 

Whereas , the undersigned Holders represent the required threshold to amend the provisions of each of the agreements referenced below.

 

Now, Therefore, in consideration of the premises and mutual covenants herein below, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.             Definitions .

 

(a)            “ July 2009 Consent Agreement ” means that certain Consent and Amendment Agreement dated as of July 6, 2009, among the Company and the Purchasers listed on Exhibit A thereto.

 

(b)            “ July 2009 Purchase Agreement ” means that certain Securities Purchase Agreement dated as of July 7, 2009, by and among the Company and the Purchasers listed on Exhibit A thereto.

 

(c)            “ Notes ” means the 2008 Notes, the April 2009 Notes and the July 2009 Notes.

 

(d)            “ Registration Rights Agreement ” means that certain Registration Rights Agreement dated as of July 7, 2009, by and among the Company and the Buyers listed on Schedule I attached thereto.

 

 

 


 

 

2.             Amendment to the July 2009 Notes .

 

The Company and the undersigned Holders representing at least two-thirds of the currently outstanding principal amount of the July 2009 Notes hereby amend each of the July 2009 Notes by deleting the definition of “Mandatory Conversion Date” in the third sentence of Section 3.1(b) and replacing such sentence with the following:

 

“As used herein, a “Mandatory Conversion Date” shall be a date, any time after January 1, 2010, on which the Daily VWAP equals or has exceeded $0.50 (as appropriately adjusted for stock splits, stock dividends, reorganizations, recapitalizations, stock combinations and the like) for each of the ten (10) consecutive prior Trading Days ending on the Trading Day immediately prior to such date; provided, that the Equity Conditions shall have been satisfied and the Common Stock shall have been Tradable on each Trading Day during the period beginning on the first day of such ten (10) day period and ending on the date of the delivery of such shares of Common Stock pursuant to the mandatory conversion.”

 

3.             Amendment to the July 2009 Consent Agreement .

 

The Company and the undersigned Holders representing the Holders of at least two-thirds of the currently outstanding and unexercised Purchase Rights (as defined in the April 2009 Consent Agreement) and the currently outstanding principal amount of New Notes (as defined in the April 2009 Consent Agreement) issued upon exercise of the Purchase Rights (together, as one class) hereby amend the July 2009 Consent Agreement as follows:

 

(a)            The first recital is hereby deleted in its entirety and replaced with the following:

 

Whereas , in order to facilitate the consummation of one or more financing transactions, which may include private placements or public offerings, under which the Company desires to raise an aggregate in all such transactions of up to $13,000,000 through the sale of securities consisting of (i) up to $9,100,000 in principal amount of Senior Unsecured Convertible Notes (the “ July 2009 Notes ”), (ii) up to $3,900,000 of common stock of the Company (the “ Common Stock ”) and (iii) related warrants (the “ Financing ”), on substantially the terms described in that certain term sheet attached hereto as Exhibit B (the “ Term Sheet ”), the parties desire to enter into this Agreement; and”

 

(b)            The reference to “aggregate amount of $7,000,000” in Section 1(d) is hereby replaced with “aggregate amount of at least $7,000,000”.

 

(c)            The second sentence of Section 2 is hereby deleted in its entirety and replaced with the following:

 

“The Company hereby agrees that prior to the consummation of the period expiring fourteen (14) days after the date on which the Company publicly releases detailed quantitative results regarding the primary assessment of progression-free survival, one of the co-primary endpoints of a Phase 3 trial of Genasense® plus chemotherapy in patients with advanced melanoma, which the Company refers to as AGENDA, without first obtaining the consent of at least two-thirds of the currently outstanding and unexercised Purchase Rights and the currently outstanding principal amount of New Notes issued upon exercise of the Purchase Rights (together, as one class), the Company shall not close or publicly announce its entry into any debt or equity financing or any other capital raising transaction or transactions with any person, other than the Financing.”

 

 

 


 

 

(d)            Section 4 is hereby deleted in its entirety and replaced with the following:

 

“4.            Covenants of the Holders .  Each Holder of a 2008 Note, and each Holder of an April 2009 Note, hereby agrees that, any time after January 1, 2010, such Holder will convert all 2008 Notes held by such Holder and all 2009 Notes held by such Holder into shares of Common Stock, including any PIK Notes, and any 2008 Notes or 2009 Notes issuable upon exercise of any Purchase Options, Purchase Rights and any other right to acquire 2008 Notes or 2009 Notes on or before the fifth Trading Day following the receipt by such Holder of the written request of the Company (the “Conversion Notice”) in the event that on the date that the Conversion Notice is sent by the Company, the Daily VWAP has exceeded $0.50 (which shall be appropriately adjusted for any stock splits, stock dividends, reorganizations, recapitalizations, stock combinations and the like) for each of the ten (10) consecutive prior Trading Days ending on the Trading Day immediately prior to such date; provided that the Equity Conditions (as defined in the April 2009 Notes) shall have been satisfied and the Common Stock shall have been Tradable (as defined in the Notes) on each Trading Day during the period beginning on the first day of such ten (10) day period and ending on the date of the delivery of such shares of Common Stock pursuant to such conversion.”

 

4.             Amendment to the July 2009 Purchase Agreement .

 

The Company and the undersigned Holders representing the Purchasers (as defined in the July 2009 Purchase Agreement) currently holding at least 66 2/3% of the principal amount of the July 2009 Notes currently outstanding hereby amend Section


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more